Found 5 matching trials
Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)
PHASE2This study is an exploratory study aiming (i) to obtain clinical experience...
Location
Multiple Locations
Study to Assess the Effect Of Alosetron On Mucosal Blood Flow
PHASE4This study will look at colonic mucosal blood flow in subjects who have tak...
Location
GSK Investigational Site
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
N/AAn observational study to evaluate LOTRONEX® in women with severe IBS-D in ...
Location
Gastroenterology Consultants Inc.
Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
PHASE3The purpose of this study is to compare the safety and effectiveness of as ...
Location
GSK Investigational Site
Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
PHASE3The purpose of this study is to compare the safety and effectiveness of dif...
Location
GSK Investigational Site